Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
WARREN, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Bellerophon Thera...